OxyContin 40 mg prolonged release tablets
*Company:
Mundipharma Pharmaceuticals Limited - Formerly Napp LaboratoriesStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 19 March 2024
File name
OxyContin 40 mg prolonged release tablets - SPC - clean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
Updated on 19 March 2024
File name
OxyContin 40 mg prolonged release tablets - SPC - clean.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 December 2023
File name
OxyContin 40 mg prolonged release tablets - SPC - clean.pdf
Reasons for updating
- Change to section 4.1 - Therapeutic indications
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 December 2023
File name
OxyContin 5 mg, 10 mg, 20 mg, 40 mg, 80 mg prolonge PIL- clean.pdf
Reasons for updating
- Change to section 1 - what the product is used for
- Change to section 3 - how to take/use
Updated on 07 December 2023
File name
OxyContin 5 mg, 10 mg, 20 mg, 40 mg and 80 mg prolonged release tablets IE - PIL.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
Updated on 26 June 2023
File name
OxyContin 40 mg prolonged release tablets - SPC_v1.0-clean.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 26 June 2023
File name
OxyContin 5 mg, 10 mg, 20 mg, 40 mg, 80 mg prolonge PIL-clean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 5 - how to store or dispose
Updated on 26 June 2023
File name
OxyContin 40 mg prolonged release tablets - SPC_v1.0-clean.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 5 - how to store or dispose
Updated on 06 April 2023
File name
OxyContin 40 mg prolonged release tablets-SPC-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
IE MAH Address Change
Updated on 06 April 2023
File name
OxyContin 5 mg, 10 mg, 20 mg, 40 mg, 80 mg-PIL-clean.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
IE MAH Address Change